We all try to do everything we can to protect ourselves from Covid 19. However, just getting the vaccine isn’t enough for some of us. Some may not even be able to get the vaccine due to complications and allergic reactions. That is why it is good to look at other ways to protect yourself and your loved ones from the virus, particularly if they are at high risk. One such option is the preventative drug Evusheld. Evusheld is a preventative therapy for adults and adolescents aged 12 and up.
What is Evusheld?
Evusheld is a medication that has been approved under the FDA’s Emergency Use Authorization act. This allows it to be distributed to select individuals for use in preventing the contracting of Covid 19.
Evusheld is a monoclonal antibody treatment for the prevention of Covid 19. Monoclonal antibodies are special antibodies made to react and replicate from one specific cell, in this case, a Covid 19 antibody. While it has not been fully approved for FDA use for the general public, it has been authorized for use during the Covid 19 pandemic and has been shown to lower the risk of catching the virus for adults and children aged 12 and up.
Who is eligible?
Evusheld is recommended for those who want prophylactic treatment for Covid 19 and those who cannot receive the standard vaccine due to allergic reactions to vaccine components.
It is also an effective option for those on immunosuppressants which cannot generate protection from the virus despite being given all available doses of the vaccine. In other words, this treatment can help those who are immunocompromised create a defensive barrier to protect against the virus. This applies to those with genetic conditions affecting the immune response and anyone with conditions that may weaken the immune system either temporarily (such as chemo treatment for cancer) or permanently, such as those with HIV/AIDS who are on corresponding medication.
Evusheld is recommended for those without Covid 19 but who want protection, especially in the event of potential exposure.
What are the side effects?
Side effects from getting Evusheld monoclonal antibody treatment can include:
Allergic reactions, while not common, are possible when receiving the treatment. You should discuss this with your doctor before deciding on the treatment. There is also the potential in some patients for a cardiac-related event. While low, it was shown that some patients with pre-existing heart conditions were at risk of a cardiac event when receiving the treatment.
To lower the risk of potential cardiac events, it is good to make sure you are up to date on all your medications, have not performed strenuous activity, or have not done anything that would aggravate an existing heart condition. It’s also good to discuss your overall risk factors with a doctor before getting treatment.
Lastly, there is a likelihood of pain, swelling, and bruising around the injection site and possible bleeding and infection. Follow all aftercare instructions to minimize these side effects.
Evusheld Antibody Therapy with Drip Hydration
Authorized by the FDA under the emergency use authorization (EUA), EVUSHELD is a treatment that may prevent COVID-19 in eligible individuals.
EVUSHELD is a monoclonal antibody therapy that aims to prevent COVID-19 in adults and adolescents aged 12 and over who meet eligibility criteria. A single dose that consists of two separate injections provides long-lasting protection against the COVID-19 virus in individuals who are not currently infected with the virus.
Appointments only take a few minutes. One of our registered nurses will come to your location to administer the injection. Contact us today to get started!